Caprock Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
7,057
-1,714
-20% -$186K 0.02% 613
2026
Q1
$810K Buy
8,771
+585
+7% +$58.7K 0.02% 602
2025
Q4
$836K Buy
8,186
+301
+4% +$26.9K 0.02% 650
2025
Q3
$532K Buy
+7,885
New +$429K 0.01% 786
2025
Q1
$385K Buy
+9,041
New +$390K 0.01% 808

Other funds holding GH

Caprock Group's GH Position: Q2 2026 in Review

Caprock Group reduced its Guardant Health (GH) stake by 20% in Q2 2026, selling an estimated $186K and leaving 7,057 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #613.

Caprock Group first reported a position in GH in Q1 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Caprock Group held 7,057 shares of Guardant Health worth $1.06M as of Q2 2026.
  • Caprock Group sold 1,714 Guardant Health shares in Q2 2026, an estimated $186K.
  • Guardant Health made up 0.02% of Caprock Group's portfolio in Q2 2026, its #613 holding.
  • Caprock Group first reported a position in Guardant Health in Q1 2025 and has held it in 5 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.